BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 572-577

  Li, Zhanxia ^a   Zhou, Songwen ^a   Zhang, Ling ^a   Su, Chunxia ^a   Hang, Jinqin ^b   Zhao, Yinmin ^a   Su, Bo ^a   Zhou, Caicun ^a  

^a TONGJI UNIVERSITY   (China)

^b People' Hospital ^*  (China)

Author keywords

Apoptosis; BIM; EGFR; Non small cell lung cancer

Indexed keywords

BIM PROTEIN; CASPASE; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

EID: 85027926988     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9470-y     Document Type: Article

References (26)

1. W Pao VA Miller KA Politi GJ Riely R Somwar MF Zakowski MG Kris H Varmus 2005 Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain PLoS Med 2 3 e73 15737014 10.1371/journal.pmed.0020073 (Pubitemid 40629469)
2. MG Kris RB Natale RS Herbst TJ Lynch Jr D Prager CP Belani JH Schiller K Kelly H Spiridonidis A Sandler KS Albain D Cella MK Wolf SD Averbuch JJ Ochs AC Kay 2003 Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer JAMA 290 2149 2158 14570950 10.1001/jama.290.16.2149 1:CAS:528: DC%2BD3sXosVOnsbo%3D (Pubitemid 37432975)
3. JG Paez PA Jänne JC Lee S Tracy H Greulich S Gabriel P Herman FJ Kaye N Lindeman TJ Boggon K Naoki H Sasaki Y Fujii MJ Eck WR Sellers BE Johnson M Meyerson 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497 1500 15118125 10.1126/science.1099314 1:CAS:528:DC%2BD2cXksVGmsbs%3D (Pubitemid 38720929)
4. L O'Connor A Strasser LA O'Reilly G Hausmann JM Adams S Cory DC Huang 1998 Bim: a novel member of the Bcl-2 family that promotes apoptosis EMBO J 17 2 384 395 9430630 10.1093/emboj/17.2.384 (Pubitemid 28045479)
5. YY He JL Huang CF Chignell 2006 Cleavage of epidermal growth factor receptor by caspase during apoptosis is independent of its internalization Oncogene 25 1521 1531 16247443 10.1038/sj.onc.1209184 1:CAS:528: DC%2BD28XitFGhtrw%3D (Pubitemid 43361937)
6. HK Berrieman L Smith SL O'Kane 2005 The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes Cancer 103 7 1415 1419 15700269 10.1002/cncr.20907 1:CAS:528:DC%2BD2MXjtFamtr8%3D (Pubitemid 40410737)
7. M Rosas KU Birkenkamp JW Lammers L Koenderman PJ Coffer 2005 Cytokine mediated suppression of TF-1 apoptosis requires PI3 K activation and inhibition of Bim expression FEBS Lett 579 1 191 198 15620712 10.1016/j.febslet.2004.11.074 1:CAS:528:DC%2BD2cXhtFGht7jE (Pubitemid 40023395)
8. J Deng T Shimamura S Perera 2007 Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion Cancer Res 67 24 11867 11875 18089817 10.1158/0008-5472.CAN-07-1961 1:CAS:528:DC%2BD2sXhsVCjs7nN
9. P Bouillet D Metcalf DC Huang DM Tarlinton TW Kay F Köntgen JM Adams A Strasser 1999 Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude to immunity Science 286 5445 1735 1738 10576740 10.1126/science.286.5445.1735 1:CAS:528:DyaK1MXnsl2nsLo%3D (Pubitemid 129515880)
10. P Bouillet JF Purton DI Godfrey LC Zhang L Coultas H Puthalakath M Pellegrini S Cory JM Adams A Strasser 2002 BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes Nature 415 6874 922 926 11859372 10.1038/415922a 1:CAS:528:DC%2BD38Xhs12jt7w%3D (Pubitemid 34174755)
11. KE Ewings CM Wiggins SJ Cook 2007 Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels Cell Cycle 6 18 2236 2240 17881896 10.4161/cc.6.18.4728 1:CAS:528:DC%2BD2sXhtlKkt7rE (Pubitemid 47547699)
12. DB Costa B Halmos A Kumar ST Schumer MS Huberman TJ Boggon DG Tenen S Kobayashi 2007 BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations PLoS Med 4 10 e315 10.1371/journal.pmed.0040315 (1669-1679) (Pubitemid 350035456)
13. Y Gong R Somwar K Politi 2007 Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas PLoS Med 4 10 e294 17927446 10.1371/journal.pmed.0040294 (Pubitemid 350035455)
14. R Ley KE Ewings K Hadfield SJ Cook 2005 Regulatory phosphorylation of Bim: sorting out the ERK from the JNK Cell Death Differ 12 1008 1014 15947788 10.1038/sj.cdd.4401688 1:CAS:528:DC%2BD2MXmtVylsr4%3D (Pubitemid 41065418)
15. DB Costa B Halmos A Kumar ST Schumer MS Huberman TJ Boggon DG Tenen S Kobayashi 2007 BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations PLoS Med 4 1669 1679 17973572 10.1371/journal.pmed.0040315 1:CAS:528:DC%2BD2sXhtl2rt7jF (Pubitemid 350035456)
16. MS Cragg J Kuroda H Puthalakath DC Huang A Strasser 2007 Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics PLoS Med 4 1681 1689 17973573 10.1371/journal.pmed.0040316 1:CAS:528:DC%2BD2sXhtl2rt7nM (Pubitemid 350035457)
17. MS Cragg J Kuroda H Puthalakath DC Huang A Strasser 2007 Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM, can be enhanced by BH3 mimetics PLoS Med 4 10 e316 10.1371/journal.pmed. 0040316 (Pubitemid 350035457)
18. V Janson K Grankvist 2007 397 POSTER Effects of cisplatin exposure on the expression of Bcl-2-family proteins: differences between cisplatin-sensitive and -resistant malignant pleural mesothelioma cells Eur J Cancer Suppl 5 4 83 10.1016/S1359-6349(07)70415-9
19. Z Li J Zhang Z Liu CW Woo CJ Thiele 2007 Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death Cell Death Differ 14 2 318 326 16778834 10.1038/sj.cdd.4401983 (Pubitemid 46092234)
20. R Li T Moudgil HJ Ross 2005 Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim Cell Death Differ 12 3 292 303 15711598 10.1038/sj.cdd.4401554 1:CAS:528:DC%2BD2MXhtlSrtrY%3D (Pubitemid 40360952)
21. KS Borensztajn F Maarten 2007 Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation Exp Cell Res 313 12 2622 2633 17531220 10.1016/j.yexcr.2007.04.014 1:CAS:528:DC%2BD2sXntFKgu7g%3D (Pubitemid 46977338)
22. Z Li J Zhao Y Du 2008 Down-regulation of 14-3-3 zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation Proc Natl Acad Sci USA 105 1 162 167 18162532 10.1073/pnas.0710905105 1:CAS:528:DC%2BD1cXpvFSjsQ%3D%3D
23. M Konopleva R Contractor T Tsao 2006 Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia Cancer Cell 10 5 375 388 17097560 10.1016/j.ccr.2006.10.006 1:CAS:528:DC%2BD28Xht1Glu7nJ (Pubitemid 44693472)
24. Greulich H, Chen T-H, Feng W, Janne PA, Alvarez JV et al. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med. 2005.
25. ML Janmaat JA Rodriguez M Gallegos-Ruiz FA Kruyt G Giaccone 2006 Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells Int J Cancer 118 209 214 16003751 10.1002/ijc.21290 1:CAS:528:DC%2BD2MXht1KgsrvP (Pubitemid 41681601)
26. L Joanne 2005 Lomas-Neira, Chun-Shiang Chung, et al. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury J Leukoc Biol 77 846 853 10.1189/jlb.1004617 (Pubitemid 40770834)